{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T17:17:05Z","timestamp":1747156625216,"version":"3.40.5"},"reference-count":27,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","brainanddevelopment.com","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain and Development"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.braindev.2024.03.004","type":"journal-article","created":{"date-parts":[[2024,3,21]],"date-time":"2024-03-21T21:30:20Z","timestamp":1711056620000},"page":"219-223","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prophylactic antiseizure medications for recurrent status epilepticus in nonsyndromic childhood epilepsy"],"prefix":"10.1016","volume":"46","author":[{"given":"Hirokazu","family":"Takeuchi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0056-8101","authenticated-orcid":false,"given":"Norimichi","family":"Higurashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yurika","family":"Toga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.braindev.2024.03.004_b0005","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1111\/epi.13121","article-title":"A definition and classification of status epilepticus\u2013Report of the ILAE Task Force on Classification of Status Epilepticus","volume":"56","author":"Trinka","year":"2015","journal-title":"Epilepsia"},{"key":"10.1016\/j.braindev.2024.03.004_b0010","doi-asserted-by":"crossref","first-page":"106286","DOI":"10.1016\/j.yebeh.2019.04.039","article-title":"The outcomes of childhood convulsive status epilepticus","volume":"101","author":"Chin","year":"2019","journal-title":"Epilepsy Behav"},{"issue":"2","key":"10.1016\/j.braindev.2024.03.004_b0015","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S2352-4642(17)30174-8","article-title":"Long-term prognosis after childhood convulsive status epilepticus: a prospective cohort study","volume":"2","author":"Pujar","year":"2018","journal-title":"Lancet Child Adolesc Health"},{"issue":"12","key":"10.1016\/j.braindev.2024.03.004_b0020","doi-asserted-by":"crossref","first-page":"4816","DOI":"10.1007\/s00415-021-10600-y","article-title":"Occurrence of status epilepticus in persons with epilepsy is determined by sex, epilepsy classification, and etiology: a single center cohort study","volume":"268","author":"Langenbruch","year":"2021","journal-title":"J Neurol"},{"issue":"3","key":"10.1016\/j.braindev.2024.03.004_b0025","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/ana.10286","article-title":"Status epilepticus in a population- based cohort with childhood-onset epilepsy in Finland","volume":"52","author":"Sillanp\u00e4\u00e4","year":"2002","journal-title":"Ann Neurol"},{"issue":"9","key":"10.1016\/j.braindev.2024.03.004_b0030","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1111\/epi.17015","article-title":"Defining Dravet syndrome: an essential pre-requisite for precision medicine trials","volume":"62","author":"Li","year":"2021","journal-title":"Epilepsia"},{"issue":"3b","key":"10.1016\/j.braindev.2024.03.004_b0035","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1590\/S0004-282X2006000500004","article-title":"Autonomic seizures and autonomic status epilepticus in early onset benign childhood occipital epilepsy (Panayiotopoulos syndrome)","volume":"64","author":"Tedrus","year":"2006","journal-title":"Arq Neuropsiquiatr"},{"issue":"3","key":"10.1016\/j.braindev.2024.03.004_b0040","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s40263-022-00898-1","article-title":"A practical guide to the treatment of Dravet syndrome with anti-seizure medication","volume":"36","author":"Strzelczyk","year":"2022","journal-title":"CNS Drugs"},{"issue":"1","key":"10.1016\/j.braindev.2024.03.004_b0045","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/ana.22368","article-title":"Distribution of febrile seizure duration and associations with development","volume":"70","author":"Hesdorffer","year":"2011","journal-title":"Ann Neurol"},{"issue":"4","key":"10.1016\/j.braindev.2024.03.004_b0050","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/epi.12550","article-title":"ILAE official report: a practical clinical definition of epilepsy","volume":"55","author":"Fisher","year":"2014","journal-title":"Epilepsia"},{"issue":"6","key":"10.1016\/j.braindev.2024.03.004_b0055","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1002\/ana.410310606","article-title":"Recurrent status epilepticus in children","volume":"31","author":"Shinnar","year":"1992","journal-title":"Ann Neurol"},{"key":"10.1016\/j.braindev.2024.03.004_b0060","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/S0140-6736(06)69043-0","article-title":"Incidence, cause, and short-term outcome of convulsive status epilepticus in childhood: prospective population-based study","volume":"368","author":"Chin","year":"2006","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.braindev.2024.03.004_b0065","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/j.1528-1167.2011.03355.x","article-title":"Revising the \u201cRule of Three\u201d for inferring seizure freedom","volume":"53","author":"Brandon Westover","year":"2012","journal-title":"Epilepsia"},{"key":"10.1016\/j.braindev.2024.03.004_b0070","first-page":"69","article-title":"Levetiracetam (levebel) Versus carbamazepine monotherapy for focal epilepsy in children: a randomized clinical trial","volume":"14","author":"Akhondian","year":"2020","journal-title":"Iran J Child Neurol"},{"issue":"02","key":"10.1016\/j.braindev.2024.03.004_b0075","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1055\/s-0037-1613680","article-title":"Effect of Levetiracetam monotherapy in nonlesional focal childhood epilepsy","volume":"49","author":"Kanemura","year":"2018","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.braindev.2024.03.004_b0080","first-page":"CD004154","article-title":"Clobazam add-on therapy for drug-resistant epilepsy","volume":"10","author":"Bresnahan","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10.1016\/j.braindev.2024.03.004_b0085","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1017\/S0317167100030651","article-title":"Clobazam as an add-on drug in the treatment of refractory epilepsy of childhood","volume":"17","author":"Keene","year":"1990","journal-title":"Can J Neurol Sci"},{"issue":"6373","key":"10.1016\/j.braindev.2024.03.004_b0090","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1136\/bmj.286.6373.1246","article-title":"Clobazam as adjunctive treatment in refractory epilepsy","volume":"286","author":"Allen","year":"1983","journal-title":"Br Med J (Clin Res Ed)"},{"issue":"1","key":"10.1016\/j.braindev.2024.03.004_b0095","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1177\/0883073812461943","article-title":"Clobazam for the treatment of intractable epilepsy in children","volume":"28","author":"Perry","year":"2013","journal-title":"J Child Neurol"},{"issue":"2","key":"10.1016\/j.braindev.2024.03.004_b0100","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1528-1157.1984.tb04168.x","article-title":"Neonatal hypoxia and epileptic risk: a clinical prospective study","volume":"25","author":"Bergamasco","year":"1984","journal-title":"Epilepsia"},{"issue":"11","key":"10.1016\/j.braindev.2024.03.004_b0105","doi-asserted-by":"crossref","first-page":"3523","DOI":"10.1073\/pnas.1415126112","article-title":"KCC2 activity is critical in limiting the onset and severity of status epilepticus","volume":"112","author":"Silayeva","year":"2015","journal-title":"PNAS"},{"issue":"12","key":"10.1016\/j.braindev.2024.03.004_b0110","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/S1474-4422(06)70626-3","article-title":"Effects of seizures on developmental processes in the immature brain","volume":"5","author":"Ben-Ari","year":"2006","journal-title":"Lancet Neurol"},{"issue":"3","key":"10.1016\/j.braindev.2024.03.004_b0115","doi-asserted-by":"crossref","first-page":"229","DOI":"10.2165\/11599020-000000000-00000","article-title":"GABA(A) receptor physiology and its relationship to the mechanism of action of the 1,5-benzodiazepine clobazam","volume":"26","author":"Sankar","year":"2012","journal-title":"CNS Drugs"},{"key":"10.1016\/j.braindev.2024.03.004_b0120","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2021.747835","article-title":"When are depolarizing GABAergic responses excitatory?","volume":"14","author":"Kilb","year":"2021","journal-title":"Front Mol Neurosci"},{"key":"10.1016\/j.braindev.2024.03.004_b0125","first-page":"236","article-title":"Efficacy and side effect profile of Clobazam in children with different etiologies of epilepsy from a single center","volume":"54","author":"Uzunhan","year":"2020","journal-title":"Sisli Etfal Hastan Tip Bul"},{"issue":"7","key":"10.1016\/j.braindev.2024.03.004_b0130","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1111\/cns.12399","article-title":"Clobazam: a safe, efficacious, and newly rediscovered therapeutic for epilepsy","volume":"21","author":"Gauthier","year":"2015","journal-title":"CNS Neurosci Ther"},{"issue":"10","key":"10.1016\/j.braindev.2024.03.004_b0135","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1111\/j.1528-1167.2008.01669.x","article-title":"How do seizures stop?","volume":"49","author":"Lado","year":"2008","journal-title":"Epilepsia"}],"container-title":["Brain and Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0387760424000433?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0387760424000433?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T16:09:48Z","timestamp":1715616588000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0387760424000433"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":27,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S0387760424000433"],"URL":"https:\/\/doi.org\/10.1016\/j.braindev.2024.03.004","relation":{},"ISSN":["0387-7604"],"issn-type":[{"type":"print","value":"0387-7604"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prophylactic antiseizure medications for recurrent status epilepticus in nonsyndromic childhood epilepsy","name":"articletitle","label":"Article Title"},{"value":"Brain and Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.braindev.2024.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}